Sarepta Plunged After Adverse Event Forces Trial Halt in the UK Post author:Sam Post published:February 11, 2018 Post category:BioPharma But the biotech swiftly indicated that it doesn’t expect the halt to last for long. Source: BioSpace You Might Also Like <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017 Samumed???s Osteoarthritis Research Selected For An Oral Presentation At A Conference August 1, 2017 PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017
